JL

Jessica Liu

Principal Opto-mechanical Engineer at AVAVA

Jessica (Jia) Liu is a Principal Opto-Mechanical Engineer at AVAVA, Inc. since October 2022, previously holding the position of Senior Opto-Mechanical Engineer. Prior experience includes roles as a Mechanical Engineer at Intelon Optics (March 2020 - October 2022) and at Massachusetts General Hospital (April 2017 - March 2020), as well as a Mechanical Engineer at GE Healthcare (February 2016 - 2017). Jessica has also contributed as a Teaching Assistant at Northeastern University in 2014, and gained practical experience through internships at Dalian University of Technology (March 2012 - December 2012) and AVIC Liming Jinxi Chemical Machinery (May 2012 - August 2012). Jessica earned a Master of Science in Mechanical Engineering from Northeastern University (2013 - 2015) and a Bachelor of Science in Process Equipment and Control Engineering from Dalian University of Technology (2009 - 2013).

Location

Boston, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


AVAVA

AVAVA™ developed a new class of FDA-cleared, non-invasive aesthetic medical devices with patented precision technology to provide best in class patient and provider experience for all skin tones. The AVAVA proprietary Focal Point Technology™ is complemented by AVAVASite, a high-resolution interactive imaging system, which provides treatment intelligence to map and guide real-time therapy with actionable data, to unlock safe and effective treatments. AVAVA received FDA Clearance 510(k) for its first two devices in 2022, the first of which, MIRIA™ will have a limited release in 2023 with broad scale commercial availability in 2024. The MIRIA System is a high energy focused intradermal laser, powered by Focal Point Technology™, that delivers energy at any depth in the skin with pinpoint accuracy, making it ideal for patients with darker skin tones. The MIRIA System delivers a high dose of conical energy to the dermis and spares the sensitive epidermis from unwanted damage — all while maintaining patient comfort and with minimal downtime. Extensive MIRIA clinical studies have demonstrated improvement in all signs of skin aging, including wrinkles, sun damage, and skin quality, as well as reduction in pitted acne scarring and large pore size across a wide range of skin types and colors. The MIRIA by AVAVA System™ will help address the needs of over 11.7 million US-individuals of all skin tones that seek facial rejuvenation each year.


Employees

11-50

Links